Endobronchial ultrasound (EBUS) and transbronchial needle aspiration (TBNA) have changed the landscape of pulmonology. Mediastinal structures beyond the confines of airway walls are visualized in real-time with EBUS, leading to improved accuracy of tissue sampling and diagnostic yield. With the development of various needle sizes ranging from 25-G to 19-G, the sampling of lymph nodes is becoming easier and more commonplace. Yet, certain conditions such as sarcoidosis and lymphoma may still be difficult to diagnose via EBUS-TBNA. Furthermore, in the age of targeted therapy, there are more demands on EBUS-TBNA samples for molecular marker testing and next-generation sequencing. Here, we present a complementary methodology, EBUS-guided intranodal forceps biopsy (EBUS-IFB), for tissue acquisition that may help address these deficiencies. Specifically, we aim to propose indications, contraindications, outline approaches in performing IFB, and provide an overview of the data for this complementary technique.
CITATION STYLE
Cheng, G., Mahajan, A., Oh, S., Benzaquen, S., & Chen, A. (2019, September 1). Endobronchial ultrasound-guided intranodal forceps biopsy (EBUS-IFB)—technical review. Journal of Thoracic Disease. AME Publishing Company. https://doi.org/10.21037/jtd.2019.08.106
Mendeley helps you to discover research relevant for your work.